The largest database of trusted experimental protocols

2 protocols using ampicillin

1

Establishing Patient-Derived Tumor Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh tumor tissue was cut into pieces with a maximum diameter of 2 mm and implanted subcutaneously in anaesthetized NMRI-nu mice (RjOrl:NMRI-Foxn1nu/Foxn1nu, Janvier Labs SAS, Saint-Berthevin, France). After harvest from euthanized animals, tumor tissue was dissociated into a single cell suspension by the GentleMACS Dissociator (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) applying a standardized protocol. In brief, tissue was minced manually and subjected to repeated cycles of mechanical stirring and enzymatic digestion. The resulting suspension was filtered and centrifugalized. The pellet was gently resuspended in a medium (Airway Epithelial Cell Growth Medium with SupplementMix, PromoCell GmbH, Heidelberg, Germany) with the addition of 50 μg/ml ampicillin (Ratiopharm GmbH, Ulm, Germany). Cells were incubated at 37°C in 5% CO2 for 4–7 days. Following that, the initial medium was gradually replaced by DMEM (Biowest, Nuaillé, France) with the addition of 10% fetal bovine serum, 14 μg/ml phosphoethanolamine, 11 μg/ml ethanolamine, 0.5 ng/ml EGF (all Biochrom AG, Berlin, Germany), 5.0 μg/ml hydrocortisone, 5.0 μg/ml insulin (Sigma-Aldrich, St. Louis, USA), 0.5 ng/ml FGF (R&D Systems Inc., Minneapolis, USA), and 50 μg/ml ampicillin.
+ Open protocol
+ Expand
2

Embryonic Stem Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For OP induction, the EBs were transferred into a plate coated with a poly-l-ornithine and laminin (both were from Sigma-Aldrich Chemical Co.)-coated plate and cultured for 3 days in an advanced Dulbecco’s modified Eagle’s medium (DMEM)/nutrient mixture F12 supplemented with 20% KSR, N2, B27 (ThermoFisher Scientific), human basic fibroblast growth factor (bFGF; 25 ng/mL; R&D Systems), human FGF19 (25 ng/mL; R&D Systems), human noggin (30 ng/mL; R&D Systems), human R-spondin1 (R&D Systems; 50 ng/mL), heparan sulphate (50 ng/mL; Sigma, USA) and ampicillin (50 µg/mL). However, the medium was replaced with the advanced DMEM/F12 supplemented with 15% KSR, N2, B27, bFGF (25 ng/mL), human FGF19 (25 ng/mL), human BMP4 (20 ng/mL; R&D Systems), heparan sulphate (50 ng/mL) and ampicillin (50 µg/mL) and cultured for 3 days5 (link),57 .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!